04:19 AM EDT, 10/06/2025 (MT Newswires) -- Eli Lilly ( LLY ) plans to invest more than $1 billion in India in the years ahead to increase manufacturing and supply via local drugmakers, Reuters reported Monday, citing the company.

Through various partnerships, Lilly intends to increase the availability of its main drugs, including those for obesity, diabetes, Alzheimer's, cancer and autoimmune conditions, the news agency reported.

"We are making significant investments to increase manufacturing and medicine supply capacity around the world," Reuters reported, citing Patrik Jonsson, president of Lilly International.

The company didn't immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)